Clearpoint Neuro Inc reports results for the quarter ended in June - Earnings Summary

Clearpoint Neuro

10/08/2021 22:15

* Clearpoint Neuro Inc  CLPT.OQ  reported a quarterly adjusted
loss of 17 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 13 cents per share.
* Revenue rose 37.7% to $3.41 million from a year ago;  analysts
expected $3.69 million. 
* Clearpoint Neuro Inc's reported EPS for the quarter was a loss
of 17 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Clearpoint Neuro Inc shares had risen by 16.1% this
quarter and gained 39.5% so far this year.
* The company reported a quarterly loss of $3.74 million.
* Wall Street's median 12-month price target for Clearpoint
Neuro Inc is $35.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 09:14 p.m.  ​All
figures in US dollars unless otherwise stated